Digoxin Monitoring Guidelines

Introduction to Digoxin Monitoring

• The European Society of Cardiology recommends checking digoxin concentration early during chronic therapy, especially in patients with renal impairment, and subsequently only when clinically indicated, such as suspected toxicity, significant changes in renal function, or initiation of interacting medications 1, 2

Key Monitoring Principles

• Check digoxin concentration early during chronic therapy in patients with normal renal function, as recommended by the European Society of Cardiology 1, 2, 3, 4, 5, 6, 7
• In patients with renal impairment, steady state takes longer to achieve and requires more cautious initial monitoring, according to the European Heart Journal 1, 2, 3, 4, 5, 6, 7

Routine Monitoring in Stable Patients

• The European Society of Cardiology states that routine serial monitoring of digoxin levels is not beneficial in stable patients 1, 2, 6, 7
• Serial monitoring of serum electrolytes and renal function is mandatory, as digoxin can cause arrhythmias particularly with hypokalemia, as recommended by the European Journal of Heart Failure 1, 2, 6

When to Check Digoxin Levels

• Suspected digoxin toxicity, such as confusion, nausea, anorexia, color vision disturbances, arrhythmias, requires checking digoxin levels, as recommended by the European Journal of Heart Failure 1, 2, 3, 4, 5, 6, 7
• Initiation of interacting medications, such as amiodarone, diltiazem, verapamil, quinidine, requires checking digoxin levels, according to the European Journal of Heart Failure 1, 2, 6, 7

Target Therapeutic Range

• Therapeutic serum concentration of digoxin is 0.6-1.2 ng/mL, as recommended by the European Journal of Heart Failure 1, 2, 6, 7

Practical Monitoring Strategy

• For patients with normal renal function, check level early during therapy and subsequently monitor only for clinical indications, such as toxicity, drug interactions, renal changes, as recommended by the European Journal of Heart Failure 1, 2, 6, 7
• For patients with renal impairment, monitor renal function and electrolytes more frequently, as recommended by the European Journal of Heart Failure 1, 2, 6, 7